127 related articles for article (PubMed ID: 20023747)
1. Multidimensional degradomics identifies systemic autoantigens and intracellular matrix proteins as novel gelatinase B/MMP-9 substrates.
Cauwe B; Martens E; Proost P; Opdenakker G
Integr Biol (Camb); 2009 Jun; 1(5-6):404-26. PubMed ID: 20023747
[TBL] [Abstract][Full Text] [Related]
2. Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases.
Cauwe B; Opdenakker G
Crit Rev Biochem Mol Biol; 2010 Oct; 45(5):351-423. PubMed ID: 20812779
[TBL] [Abstract][Full Text] [Related]
3. Updated biological roles for matrix metalloproteinases and new "intracellular" substrates revealed by degradomics.
Butler GS; Overall CM
Biochemistry; 2009 Nov; 48(46):10830-45. PubMed ID: 19817485
[TBL] [Abstract][Full Text] [Related]
4. Adenylyl cyclase-associated protein-1/CAP1 as a biological target substrate of gelatinase B/MMP-9.
Cauwe B; Martens E; Van den Steen PE; Proost P; Van Aelst I; Blockmans D; Opdenakker G
Exp Cell Res; 2008 Sep; 314(15):2739-49. PubMed ID: 18671965
[TBL] [Abstract][Full Text] [Related]
5. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade.
Vandooren J; Van den Steen PE; Opdenakker G
Crit Rev Biochem Mol Biol; 2013; 48(3):222-72. PubMed ID: 23547785
[TBL] [Abstract][Full Text] [Related]
6. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors.
Overall CM; Tam EM; Kappelhoff R; Connor A; Ewart T; Morrison CJ; Puente X; López-Otín C; Seth A
Biol Chem; 2004 Jun; 385(6):493-504. PubMed ID: 15255181
[TBL] [Abstract][Full Text] [Related]
7. Gelatinase B functions as regulator and effector in leukocyte biology.
Opdenakker G; Van den Steen PE; Dubois B; Nelissen I; Van Coillie E; Masure S; Proost P; Van Damme J
J Leukoc Biol; 2001 Jun; 69(6):851-9. PubMed ID: 11404367
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase proteomics: substrates, targets, and therapy.
Morrison CJ; Butler GS; Rodríguez D; Overall CM
Curr Opin Cell Biol; 2009 Oct; 21(5):645-53. PubMed ID: 19616423
[TBL] [Abstract][Full Text] [Related]
9. Degradomics: systems biology of the protease web. Pleiotropic roles of MMPs in cancer.
Overall CM; Dean RA
Cancer Metastasis Rev; 2006 Mar; 25(1):69-75. PubMed ID: 16680573
[TBL] [Abstract][Full Text] [Related]
10. On the roles of extracellular matrix remodeling by gelatinase B.
Opdenakker G
Verh K Acad Geneeskd Belg; 1997; 59(6):489-514. PubMed ID: 9543820
[TBL] [Abstract][Full Text] [Related]
11. Differential induction of gelatinase B (MMP-9) and gelatinase A (MMP-2) in T lymphocytes upon alpha(4)beta(1)-mediated adhesion to VCAM-1 and the CS-1 peptide of fibronectin.
Yakubenko VP; Lobb RR; Plow EF; Ugarova TP
Exp Cell Res; 2000 Oct; 260(1):73-84. PubMed ID: 11010812
[TBL] [Abstract][Full Text] [Related]
12. [Type IV collagenases (MMP-2 and MMP-9) and their substrates--intracellular proteins, hormones, cytokines, chemokines and their receptors].
Hrabec E; Naduk J; Strek M; Hrabec Z
Postepy Biochem; 2007; 53(1):37-45. PubMed ID: 17718386
[TBL] [Abstract][Full Text] [Related]
13. Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model.
Karagiannis ED; Popel AS
J Theor Biol; 2006 Jan; 238(1):124-45. PubMed ID: 16005020
[TBL] [Abstract][Full Text] [Related]
14. Protease proteomics: revealing protease in vivo functions using systems biology approaches.
Doucet A; Overall CM
Mol Aspects Med; 2008 Oct; 29(5):339-58. PubMed ID: 18571712
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U
J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517
[TBL] [Abstract][Full Text] [Related]
16. Expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinases during mouse embryonic development.
Chen L; Nakai M; Belton RJ; Nowak RA
Reproduction; 2007 Feb; 133(2):405-14. PubMed ID: 17307908
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of breast cancer cell extracellular matrix degradative activity by chemically modified tetracyclines.
Gu Y; Lee HM; Golub LM; Sorsa T; Konttinen YT; Simon SR
Ann Med; 2005; 37(6):450-60. PubMed ID: 16203617
[TBL] [Abstract][Full Text] [Related]
18. Discovery of chemokine substrates for matrix metalloproteinases by exosite scanning: a new tool for degradomics.
Overall CM; McQuibban GA; Clark-Lewis I
Biol Chem; 2002; 383(7-8):1059-66. PubMed ID: 12437088
[TBL] [Abstract][Full Text] [Related]
19. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
Fridman R; Toth M; Peña D; Mobashery S
Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967
[TBL] [Abstract][Full Text] [Related]
20. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia.
Klein G; Vellenga E; Fraaije MW; Kamps WA; de Bont ES
Crit Rev Oncol Hematol; 2004 May; 50(2):87-100. PubMed ID: 15157658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
